References

References

  1. Krishnamurthi, R., Hale, L., Barker-Collo, S., Theadom, A., Bhattacharjee, R., George, A., Parmar, P., . . . Feigin, V. (2018). Mobile technology for primary stroke prevention. Stroke, 50, 196-198. doi:10.1161/STROKEAHA.118.023058
  2. Feigin VL, Norrving B, Mensah GA. (2017). Primary prevention of cardiovascular disease through population-wide motivational strategies: Insights from using smartphones in stroke prevention. BMJ Global Health, 2(2). doi: 10.1136/bmjgh-2017-000306.
  3. Parmar P, Krishnamurthi R, Ikram MA, et. al. (2015). The Stroke Riskometer(TM) App: Validation of a data collection tool and stroke risk predictor. International Journal of Stroke, 10(2), 231-44 doi: 10.1111/ijs.12411.
  4. Krishnamurthi R, Bhattacharjee R, Parmar P, et. al. (2018). Effectiveness of the Stroke Riskometer app for primary stroke prevention: A pilot RCT. Late-Breaking News Science Abstracts of the 2018 International Stroke Conference, Los Angeles, USA. Presentation Number LBP18, page 85.
  5. Feigin VL. (2017). Primary stroke prevention needs overhaul. International Journal of stroke, 12(1), 5-6. doi: 10.1177/1747493016669850.
  6. Kowalski RG, et. al. (2017). Acute Ischemic stroke after moderate to severe Traumatic Brain Injury: Incidence and impact on outcome. Stroke, 48(7), 1802-1809.
  7. Feigin VL, Varakin YY, Kravchenko MA, et. al. (2016). A new approach to stroke prevention in Russia. Human Physiology, 42(8), 854-57. doi: 10.1134/s0362119716080053.
  8. Feigin VL, Roth GA, Naghavi M, et. al. (2016). Global burden of stroke and risk factors in 188 countries, during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet Neurology, 15(9), 913-24. doi: 10.1016/S1474-4422(16)30073-4.
  9. O'Donnell MJ, Chin SL, Rangarajan S, et. al. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. The Lancet, 388(10046), 761-75. doi: 10.1016/s0140-6736(16)30506-2.
  10. Feigin VL, Norrving B, George MG, Foltz JL, Roth GA, Mensah GA. (2016). Prevention of stroke: A strategic global imperative. Nature Reviews Neurology, 12(9), 501-512. doi: 10.1038/nrneurol.2016.107.
  11. Feigin VL, Wang W, Fu H, et. al. (2015). Primary stroke prevention in China - a new approach. Neurological Research, 37(5), 378-380. doi: 10.1179/1743132815Y.0000000025.
  12. Feigin VL, Krishnamurthi R, Bhattacharjee R, et. al. (2015). New strategy to reduce the global burden of stroke. Stroke, 46(6), 1740-1747. doi: 10.1161/STROKEAHA.115.008222.
  13. Brindle P, Emberson J, Lampe F, et. al. (2003). Predictive accuracy of the Framingham coronary risk score in British men: Prospective cohort study. British Medical Journal, 327(7426), 1267-1270.
  14. Rostamian S, et. al. (2014). Cognitive impairment and risk of stroke. Stroke, 45, 1342-1348.
  15. Sajjad A, Mirza SS, Portegies MLP, et. al. (2015). Subjective memory complaints and the risk of stroke. Stroke, 46(1), 170-175. doi: 10.1161/STROKEAHA.114.006616.
  16. Feigin VL, Norrving B. (2014). A new paradigm for primary prevention strategy in people with elevated risk of stroke. International Journal of Stroke, 9(5), 624-626. doi: 10.1111/ijs.12300.
  17. D'Agostino. (2008). General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation, 117, 743-753. doi: 10.1161/CIRCULATIONAHA.107.699579.
  18. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. (1994). Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study. Stroke, 25(1), 40-43.